CVE-2018-14787: Philips Intellispace Cardiovascular

High severity, CVSS 7.8. EPSS: 0.4% chance of exploitation in the next 30 days.

In Philips' IntelliSpace Cardiovascular (ISCV) products (ISCV Version 2.x or prior and Xcelera Version 4.1 or prior), an attacker with escalated privileges could access folders which contain executables where authenticated users have write permissions, and could then execute arbitrary code with local administrative permissions.

Affected products

• Philips Intellispace Cardiovascular: up to and including 3.1
• Philips Xcelera: up to and including 4.1

Published 2018-08-22. Last modified 2026-06-17.